Immunoprecise Antibodies Ltd (IPA)

Jan 28, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 3.9% – Here’s Why - Defense World

Jan 28, 2025

Jan 27, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Unveils AI-Developed GLP-1 Therapies for Type 2 Diabetes and Obesity, Pioneering New Frontiers in Biotech Innovation - Insider Monkey

Jan 27, 2025

Jan 27, 2025

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture - The Globe and Mail

Jan 27, 2025

Jan 27, 2025

ImmunoPrecise Antibodies Strengthens Financial Position with Strategic Capital Initiatives - TipRanks

Jan 27, 2025

Jan 27, 2025

ImmunoPrecise Antibodies Raises $7M, Eliminates Debt Through Strategic Financing - StockTitan

Jan 27, 2025

Jan 24, 2025

Benchmark maintains Buy on Immunoprecise stock, target at $3.00 - MSN

Jan 24, 2025

Jan 24, 2025

Benchmark maintains Buy on Immunoprecise stock, target at $3.00 By Investing.com - Investing.com Canada

Jan 24, 2025

Jan 23, 2025

Immunoprecise uses AI to develop new class of GLP-1 therapies - BioWorld Online

Jan 23, 2025

Jan 23, 2025

ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI - Yahoo Finance

Jan 23, 2025

Jan 23, 2025

Stock Traders Buy High Volume of ImmunoPrecise Antibodies Call Options (NASDAQ:IPA) - Defense World

Jan 23, 2025

Jan 22, 2025

What's Going On With ImmunoPrecise Antibodies Stock Wednesday? - Benzinga

Jan 22, 2025

Jan 22, 2025

S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail

Jan 22, 2025

Jan 22, 2025

TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail

Jan 22, 2025

Jan 22, 2025

TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail

Jan 22, 2025

Jan 22, 2025

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Jan 22, 2025

Jan 22, 2025

ImmunoPrecise Antibodies Leverages AI for Next-Gen Diabetes Treatment - TipRanks

Jan 22, 2025

Jan 22, 2025

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment - Business Wire

Jan 22, 2025

Jan 20, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Launches AI-Powered Drug Discovery Pipeline, Revolutionizing Therapeutic Development with LENSai™ Platform - Insider Monkey

Jan 20, 2025

Jan 20, 2025

10 Trending AI Stocks on Latest News and Ratings - Insider Monkey

Jan 20, 2025

Jan 17, 2025

ImmunoPrecise launches AI-driven drug discovery pipeline - Investing.com India

Jan 17, 2025

Jan 17, 2025

ImmunoPrecise launches AI-driven drug discovery pipeline By Investing.com - Investing.com Canada

Jan 17, 2025

Jan 17, 2025

ImmunoPrecise Antibodies Launches AI-Powered Drug Discovery Platform - TipRanks

Jan 17, 2025

Jan 17, 2025

ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation - Business Wire

Jan 17, 2025

Jan 17, 2025

Even With A 30% Surge, Cautious Investors Are Not Rewarding ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Performance Completely - Simply Wall St

Jan 17, 2025

Jan 04, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Up 15.5% – What’s Next? - Defense World

Jan 04, 2025

Jan 03, 2025

ImmunoPrecise Antibodies Announces CFO Resignation - TipRanks

Jan 03, 2025

Jan 02, 2025

ImmunoPrecise Antibodies finance chief to step down - MSN

Jan 02, 2025

Jan 02, 2025

ImmunoPrecise Antibodies announces resignation of CFO - Yahoo Finance

Jan 02, 2025

Dec 31, 2024

ImmunoPrecise Antibodies Ltd. Announces the Resignation of Kristin Taylor as Chief Financial Officer, Effective January 16, 2025 - Marketscreener.com

Dec 31, 2024

Dec 31, 2024

ImmunoPrecise Antibodies CFO Resignation and Succession - TipRanks

Dec 31, 2024

Dec 31, 2024

ImmunoPrecise Antibodies CFO Kristin Taylor Announces Resignation, Will Transition Through January 2025 - StockTitan

Dec 31, 2024

Dec 31, 2024

IPA Announces Resignation of Chief Financial Officer - Business Wire

Dec 31, 2024

Dec 23, 2024

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases - The Globe and Mail

Dec 23, 2024

Dec 23, 2024

ImmunoPrecise CEO Leads Major $306K Insider Stock Purchase, Signals Confidence in AI-Driven Strategy - StockTitan

Dec 23, 2024

Dec 19, 2024

ImmunoPrecise Antibodies to Present at Microcap Conference 2025: AI-Driven Biotech Showcase - StockTitan

Dec 19, 2024

Dec 19, 2024

ImmunoPrecise Antibodies to Showcase at Microcap Conference - TipRanks

Dec 19, 2024

Dec 19, 2024

IPA to Present at The Microcap Conference 2025 - Business Wire

Dec 19, 2024

Dec 14, 2024

HC Wainwright Has Optimistic Outlook of IPA Q3 Earnings - Defense World

Dec 14, 2024

Dec 13, 2024

Research Analysts Set Expectations for IPA FY2028 Earnings - Defense World

Dec 13, 2024

Dec 12, 2024

Immunoprecise shares target cut, retains buy rating on potential By Investing.com - Investing.com Nigeria

Dec 12, 2024

Dec 12, 2024

Immunoprecise shares target cut, retains buy rating on potential - Investing.com

Dec 12, 2024

Dec 11, 2024

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript - Insider Monkey

Dec 11, 2024

Dec 11, 2024

ImmunoPrecise Antibodies Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Dec 11, 2024

Dec 11, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlights: Strategic Moves and Growth ... - Yahoo Finance

Dec 11, 2024

Dec 11, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlig - GuruFocus.com

Dec 11, 2024

Dec 11, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlights: Strategic Moves and Growth ... By GuruFocus - Investing.com Canada

Dec 11, 2024